Cargando…
Combination immunotherapy for cancer
Autor principal: | Fearon, Douglas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4925029/ https://www.ncbi.nlm.nih.gov/pubmed/27353088 http://dx.doi.org/10.1084/jem.2137insight2 |
Ejemplares similares
-
Immunotherapy and the belly of the beast
por: Merghoub, Taha, et al.
Publicado: (2014) -
A potential novel option for cancer immunotherapy – TLR7 stimulation inhibits malignant melanoma bone invasion
por: Katagiri, Takenobu
Publicado: (2018) -
Cancer immunotherapy in routine cost‐effective cancer care?
por: Feldmann, Sir Marc
Publicado: (2018) -
Harnessing combined p19Arf and interferon-beta gene transfer as an inducer of immunogenic cell death and mediator of cancer immunotherapy
por: Hunger, Aline, et al.
Publicado: (2017) -
Immunotherapy and fatigue: what we know and what we don’t know
por: Azeem Khan, Muhammad, et al.
Publicado: (2021)